Douglas Tsao's
Stock Forecasts
0%
0/19 win trades
Price targets by Douglas Tsao
Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|
![]() Apellis Pharmaceuticals, Inc. APLS | 10 months ago | $57 114.12% upside | $27.01 | StreetInsider | |
![]() Sage Therapeutics, Inc. SAGE | 10 months ago | $14 61.10% upside | $8.48 | TheFly | Previous targets (0) |
![]() Daré Bioscience, Inc. DARE | 11 months ago | $12 482.52% upside | $3.5 | StreetInsider | Previous targets (0) |
![]() Alkermes plc ALKS | 11 months ago | $37 27.58% upside | $28.91 | StreetInsider | Previous targets (0) |
![]() Xenon Pharmaceuticals Inc. XENE | 11 months ago | $53 41.86% upside | $39.37 | TheFly | Previous targets (0) |
![]() Biohaven Pharmaceutical Holding Company Ltd. BHVN | 12 months ago | $59 280.89% upside | $45.94 | StreetInsider | Previous targets (0) |
![]() Disc Medicine, Inc. IRON | 12 months ago | $70 20.31% upside | $47.79 | StreetInsider | Previous targets (0) |
![]() Protagonist Therapeutics, Inc. PTGX | 12 months ago | $50 -11.03% downside | $45.08 | StreetInsider | |
![]() Theravance Biopharma, Inc. TBPH | about 1 year ago | $15 11.52% upside | $9.59 | TheFly | Previous targets (0) |
![]() argenx SE ARGX | about 1 year ago | $533 -18.86% downside | $492.07 | StreetInsider | |
![]() Revance Therapeutics, Inc. RVNC | over 1 year ago | $11 201.36% upside | $4.29 | TheFly | Previous targets (0) |
![]() Viridian Therapeutics, Inc. VRDN | over 1 year ago | $27 51.60% upside | $14.9 | StreetInsider | Previous targets (0) |
![]() Minerva Neurosciences, Inc. NERV | over 1 year ago | $7 204.34% upside | $2.4 | StreetInsider | Previous targets (0) |
![]() Evotec SE EVO | over 1 year ago | $11 202.19% upside | $5.23 | StreetInsider | Previous targets (0) |
![]() Roivant Sciences Ltd. ROIV | over 1 year ago | $18 51.26% upside | $10.92 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Daan Vandenberk
Kepler Capital
100%
win rate
Covering:
Laura Sutcliffe
UBS
50%
win rate
Allison Bratzel
Piper Sandler
20%
win rate